Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on September 25, 2007
JNCI Journal of the National Cancer Institute 2007 99(19):1424-1425; doi:10.1093/jnci/djm166
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/19/1424    most recent
djm166v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Mandel, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandel, J. S.
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

EDITORIALS

Which Colorectal Cancer Screening Test Is Best?

Jack S. Mandel

Correspondence to: Jack S. Mandel, PhD/MPH, Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Road, NE Atlanta, GA 30322 (e-mail: jsmande@emory.edu).

The first 10% of the full text of this article appears below.

The benefit of colorectal cancer screening using a test for blood in stool (Hemoccult) was established in 1993 (1). Subsequently, this result was corroborated in two other randomized controlled trials, leading to recommendations in many countries for colorectal cancer screening (2,3). In the United States, the current recommendations include a number of screening tests in addition to Hemoccult, but other than Hemoccult none of the tests have been proven to be effective through a randomized controlled trial. However, it can be assumed that all are effective to some extent, given what is known about these tests . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Screening for Colorectal Neoplasms With New Fecal Occult Blood Tests: Update on Performance Characteristics
James E. Allison, Lori C. Sakoda, Theodore R. Levin, Jo P. Tucker, Irene S. Tekawa, Thomas Cuff, Mary Pat Pauly, Lyle Shlager, Albert M. Palitz, Wei K. Zhao, J. Sanford Schwartz, David F. Ransohoff, and Joseph V. Selby
J Natl Cancer Inst 2007 99: 1462-1470. [Abstract] [Full Text] [PDF]

IN THIS ISSUE
J Natl Cancer Inst 2007 99: 1421. [Extract] [Full Text] [PDF]

Press Release: Possible Replacement Found for Common Colorectal Cancer Test
Liz Savage and Andrea Widener
J Natl Cancer Inst 2007 99: 1421. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 cfpHome page
G. Pineau
Should Canadians be offered systematic screening for colorectal cancer?: YES
Can Fam Physician, April 1, 2008; 54(4): 504 - 505.
[Full Text] [PDF]

Home page
 cfpHome page
G. Pineau
Devrait-on offrir aux Canadiens le depistage systematique du cancer colorectal?: OUI
Can Fam Physician, April 1, 2008; 54(4): 508 - 510.
[Full Text] [PDF]